China Pharma Holdings, Inc.
CPHI· NYSE
Filed Nov 10, 2011 · 10-Q · 41 days after period end · 0001010549-11-001255
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $20.99M | $18.68M |
| Net Income | $3.29M | $5.91M |
| EPS Diluted | $0.11 | $0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 10, 2011 · 41 d after period end